Virus-like Particles For The Induction Of Autoantibodies


The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.

Owners (US)

Information currently unavailable.

CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 20, 2009
  • Application: May 1, 2006
    US US 41561106 A
  • Priority: May 1, 2006
    US US 41561106 A
  • Priority: May 3, 2005
    DE DE 102005020537 A
  • Priority: Jun 14, 2004
    US US 86711904 A
  • Priority: Sep 24, 2002
    US US 25344302 A
  • Priority: Apr 13, 2001
    US US 83512401 A
  • Priority: Oct 20, 1999
    US US 9924548 W
  • Priority: Oct 21, 1998
    US US 10513298 P

Download Citation

Sign in to the Lens